Low dose resulted in 89% median disabling seizure reduction in participants with MTS during the 7-12-month primary efficacy ...
BUFFALO, N.Y. — There is new research happening at Roswell Park Comprehensive Cancer Center to see if CAR T-cell therapy that ...
Novo Nordisk will be happy with the results after Pfizer has dropped two SCD assets in recent years. Credit: JHVEPhoto / ...
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...
Cerebral Palsy Center reports Kidswell Bio is advancing stem cell therapy for cerebral palsy in the U.S., focusing on cells ...
Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s ...
Results of the single-center, phase 2 CAR-PRISM (PRecision Intervention Smoldering Myeloma) clinical trial, the first to ...
CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...
CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...
Smithsonian Magazine on MSN
In a first, this personalized cell therapy treated three life-threatening autoimmune diseases in one patient
A personalized therapy involving re-engineered cells has brought phenomenal results for a woman with a rare trio of ...
Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...
After six weeks in the hospital, 23‑year‑old Daniel Cressy leaves with hope for a functional cure and a future where he can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results